[1] 陈 彪. miRNA在原发性肝癌中的研究进展[J]. 临床肿瘤学杂志,2012,17(10):946-950.
[2] Pineau P,Volinia S,McJunkin K,et al. MiR-221 overexpression contributes to liver tumorigebesis[J]. Proc Natl Acad Sci USA,2010, 107(1):264-269.
[3] Meng F,Henson R,Wehbe-Janek H,et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer[J]. Gastroenterology,2007,133(2):647-658.
[4] Pogribny IP,Tryndyak VP,Boyko A,et al. Induction of microRNA omederegulation in rat liver by long-term tamoxifen exposure[J]. Mutat Res,2007,619(1/2):30-37.
[5] Murakami Y,Yasuda T,Saigo K,et al. Comprehensive analysis of microRNA expression patterns in hepatocelular carcinoma and nontumorous tissues[J]. Oncogene,2006,25(17):2537-2545.
[6] Yao J,Liang L,Huang S,et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in Hepatocellular carcinoma[J]. Hepatology,2010,51(3):846-856.
[7] Garcon M,Di leva C,Romano,et al. miRNA-221 and miRNA-222 regulate TRALI,resistance and enhance tumorigenicity through PTEN and TIMP3 nonregulated[J]. Cancer Cell,2009,16(6):498-509.
[8] Mi-Kyung Song,Yong-Keun Park,Jae-Chun Ryu,et al. Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5,regulating the activation of p38 MAPK[J]. Toxicol Appl Pharmacol,2013,273(1):130–139.
[9] Su H,Yang JR,Xu T,Huang J,et al. MicroRNA-101, downregulated in hepatocellular carcinoma,promotes apoptosis and suppresses tumorigenicity[J]. Cancer Res,2009,69(3):1135-1142.
[10] Xiong Y,Fang JH,Yun JP,et al. Effects of microRNA-29 on apoptosis,tumori-genicity,and prognosis of hepatocellular carcinoma [J]. Hepatology,2010,51:836-845.
[11] Zheng Y,Yin L,Chen H,et al. MiR-376a suppresses profilerationg and induces apoptosis in hepatocellular carcinoma[J]. FEBS Lett, 2012,586(16):2396-2403.
[12] Li LM,Hu ZB,Zhou ZX,et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma[J]. Cancer Res,2010,70(23):9798-9807.
[13] Qu KZ,Zhang K,Li H,et al. Cobalt and Inorganic Cobalt Compounds [J]. J Clin Gastroenterol,2011,45(4): 355-360.
[14] Florie B,Pavlina K,Peter LM,et al. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma[J]. J Hepatol,2012,56(6):1371-1383.
[15] Sukata T,Sumida K,Kushida M,et al. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages[J]. Toxicol Lett,2011,200(1/2):46-52.
[16] 刘建华,程 涛,王洪敏,等. 血清miRNA表达水平检测与原发性肝癌早期诊断的研究[J]. 热带医学杂志,2010,10(6):666-668.
[17] Yamamoto Y,Kosaka N,Tanaka M,et al. MicroRNA-500 as a potential diagnostic marker for hepatocelluar carcinoma[J]. Biomarkers, 2009,14(7):529-538.
[18] Kota J,Chivukula RR,ODonnell KA,et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model[J]. Cell,2009,137(6):1005-1017.
[19] 漆仲春,李 华,李 东,等. MicroRNA在原发性肝癌中的研究进展[J]. 肿瘤预防与治疗,2012,25(6):389-393.
[20] Gramantieri L,Ferracin M,Fornari F,et al. Cyclin G1 is a target of miR-122a,a microRNA frequently domn-regulated in human hepatocellular carcinoma[J]. Cancer Res,2007,67(13):6092-6099.
[21] Lin CJ,Gong HY,Tseng HC,et al. miR-122 targets an anti-apoptotic gene,Bcl-w,in human hepatocellular carcinoma cell lines[J]. Biochem Res Commun,2008,375(3):315-320.
[22] Lamba V,Ghodke Y,Guan W,et al. microRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450[J]. Biochem Biophys Res Commun,2014,445(2):404-411.
[23] Fornari F,Gramantieri L,Milazzo M,et al. microRNA-519d is up-regulated in hepatocellular carcinoma and sensitizes HCC cells to doxorubicin treatment by targeting CDKN1A/P21[J]. J Hepatol,2011, 54(Sup 1):88.
[24] 张 勇,李德春,郭子健,等. Stat3 mRNA 靶向MicroRNA 重组质粒的构建及其在HepG2 肝癌细胞系中的表达[J]. 苏州大学学报:医学版,2011,31(4):543-548.
[25] Ma L,Liu J,Shen J,et al. Expression of rniRNA-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cacer cells[J]. Cancer Bio Ther,2010,9(7):554-561.
[26] Saito Y,Liang G,Egger G,et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells[J]. Cancer Cell,2006, 9(6):435-443.
[27] Sato F,Hatano E,Kitamura K,et al. MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria[J]. PLoS ONE,2011,6(1):el6435.
[28] Jiang J,Gusev Y,Aderca I,et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis,and patient survival[J]. Clin Cancer Res,2008, 14(2): 419-427.
[29] Budhu A,Jia HL,Forgues M,et al. Identification of metastasis-related microRNAs in hepatocellulae caicinoma[J]. Hepatology,2008, 47(3):897-907.
[30] Huang YH,Lin KH,Chen HC,et al. Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma[J]. PLoS ONE,2012,7(5):e37188.
[31] Ji J,Yu L,Yu Z,et al. Development of a miR-26 Companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular Carcinoma[J]. Int J Biol Sci,2013,9(3):303-312.
[32] 张志成. miRNA在肝细胞癌中的研究进展[J]. 中国误诊学杂志,2011,11(32):7839-7840. |
